DataMeds AI Profit Margin 2024-2026 | MEDS
Current and historical gross margin, operating margin and net profit margin for DataMeds AI (MEDS) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. DataMeds AI net profit margin as of June 30, 2026 is -1100.16%.
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.003B | $0.023B |
| DataMeds AI Inc. is a health IT company which focuses on the vertical integration of technology, pharmacy, pharmaceutical-adjacent and telemedicine business units to deliver a healthcare experience for consumers. The company incorporates the artificial intelligence platform EinsteinRx(TM) and blockchain-enabled smart contacts platform PharmacyChain(TM). DataMeds AI Inc., formerly known as Wellgistics Health, is based in TAMPA, Fla. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $43.014B | 42.92 |
| Tempus AI (TEM) | United States | $11.225B | 0.00 |
| 10x Genomics (TXG) | United States | $9.135B | 0.00 |
| Hinge Health (HNGE) | United States | $7.649B | 73.48 |
| Hims & Hers Health (HIMS) | United States | $6.722B | 0.00 |
| Doximity (DOCS) | United States | $4.704B | 29.00 |
| Heartflow (HTFL) | United States | $4.308B | 0.00 |
| IRhythm Holdings (IRTC) | United States | $3.782B | 249.39 |
| Clover Health Investments (CLOV) | United States | $2.709B | 0.00 |
| Privia Health (PRVA) | United States | $2.667B | 99.43 |
| Inspire Medical Systems (INSP) | United States | $2.149B | 32.74 |
| Butterfly Network (BFLY) | United States | $1.973B | 0.00 |
| Schrodinger (SDGR) | United States | $1.532B | 0.00 |
| Omnicell (OMCL) | United States | $1.524B | 21.76 |
| Azenta (AZTA) | United States | $1.404B | 76.29 |
| Enovis (ENOV) | United States | $1.051B | 5.44 |
| Talkspace (TALK) | United States | $0.879B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.659B | 0.00 |
| Phreesia (PHR) | United States | $0.647B | 34.73 |
| Claritev (CTEV) | United States | $0.618B | 0.00 |
| Veradigm (MDRX) | United States | $0.593B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.568B | 0.00 |
| Evolent Health (EVH) | United States | $0.464B | 0.00 |
| Carlsmed (CARL) | United States | $0.419B | 0.00 |
| Senseonics Holdings (SENS) | United States | $0.370B | 0.00 |
| CapsoVision (CV) | United States | $0.326B | 0.00 |
| Standard BioTools (LAB) | United States | $0.273B | 0.00 |
| American Well (AMWL) | United States | $0.230B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.144B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.137B | 0.00 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.132B | 0.00 |
| CareCloud (CCLD) | United States | $0.089B | 6.53 |
| Pulmonx (LUNG) | United States | $0.085B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.065B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.062B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.060B | 0.00 |
| Outset Medical (OM) | United States | $0.059B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.050B | 0.00 |
| Precipio (PRPO) | United States | $0.049B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.035B | 0.00 |
| 111 (YI) | China | $0.031B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.026B | 0.00 |
| HeartBeam (BEAT) | United States | $0.023B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.020B | 0.00 |
| HeartSciences (HSCS) | United States | $0.014B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.011B | 0.00 |
| Lunai Bioworks (LNAI) | United States | $0.010B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.009B | 0.00 |
| ITonic Holdings (ITOC) | China | $0.005B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.003B | 0.00 |
| PROFUSA (PFSA) | United States | $0.002B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.001B | 0.00 |
| Zhongchao (ZCMD) | China | $0.001B | 0.00 |
| TruBridge (TBRG) | United States | $0.000B | 0.00 |